BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of ...

Ultra‑Sensitive, Non‑Invasive Surveillance Solution Expected to Launch Commercially in the U.S. in 2027 as Part of CareDx’s Transplant+ Precision Medicine Portfolio BRISBANE, Calif., February 12, 2026 ...

We appreciate Dr. Tammemägi’s letter with regard to our recent article (1), but we disagree in some respects with his perspective and note a number of arithmetical and conceptual errors. Dr. Tammemägi ...

BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of ...

Objectives This study describes the prototype testing and clinical validation of the Fit-Frailty App, a fully guided, interactive mobile health (mHealth) app to assess frailty and sarcopenia. This ...

Hospitals are facing a steady rise in payment disputes over their assignment of a Diagnosis Related Group (DRG). These disputes fall into two general categories: coding-based DRG downgrades and ...

By utilizing a standardized methodology for evaluating novel digital measures, sDHT developers, biostatisticians and clinical researchers will be able to navigate the complex validation landscape more ...

Abstract: Objective: Neonatal late-onset sepsis (LOS) is a life-threatening condition in preterm infants in neonatal intensive care units (NICUs), with early detection being crucial for improving ...

Deep-Learning Model for Real-Time Prediction of Recurrence in Early-Stage Non–Small Cell Lung Cancer: A Multimodal Approach (RADAR CARE Study) Within 126 QPOP cases, 105 (52 B-NHL and 53 NK/T-NHL) ...

AdventHealth’s Shawnee Mission Medical Center is suing Blue Cross and Blue Shield of Kansas City, alleging the insurer improperly withheld more than $2 million in payments by denying hundreds of valid ...